| Literature DB >> 34274401 |
Iuliia Pilipenko1, Viktor Korzhikov-Vlakh1, Annika Valtari2, Yurii Anufrikov1, Stanislav Kalinin1, Marika Ruponen2, Mikhail Krasavin1, Arto Urtti3, Tatiana Tennikova4.
Abstract
Mucoadhesive formulations capable of situ gelation are promising for improving ocular drug delivery. Here we investigated two types of nanogels based on anionic glycosaminoglycans with grafted thermo-responsive poly(N-isopropylacrylamide) chains. One type of nanogels were formed by thermo-induced gelling of heparin-graft-poly(N-isopropylacrylamide) and chondroitin sulfate-graft-poly(N-isopropylacrylamide) copolymers. Another type of nanogels was based on the same copolymers, but terminal groups of thermosensitive macromolecular chains were modified to form covalent disulfide cross-links. All types of nanogels were studied towards their ability to encapsulate and release model drug - dexamethasone. Mucoadhesivity of both thermo-gelled and covalently cross-linked polymeric systems, as well as their ability to interact with dexamethasone, was assessed by microscale thermophoresis (MST). Mucoadhesion properties were also evaluated by isothermal titration calorimetry (ITC), which were in good correlation with MST data. The presence of disulfide linkages and thiol groups were shown to favor improved binding of cross-linked nanogels to mucin. Moreover, in vivo intraocular pressure studies showed that presence of polymers in solution can alter the ocular absorption of carbonic anhydrase inhibitor from eyedrops. The pharmacological effect was in line with mucoadhesive properties of these copolymers.Entities:
Keywords: Carbonic anhydrase inhibitor; Chondroitin sulfate; Heparin; Microscale thermophoresis; Mucoadhesion; Ocular drug delivery; Poly(N-isopropylacrylamide)
Mesh:
Substances:
Year: 2021 PMID: 34274401 DOI: 10.1016/j.ijbiomac.2021.07.070
Source DB: PubMed Journal: Int J Biol Macromol ISSN: 0141-8130 Impact factor: 6.953